fda warning letters glp-1 compounded september 2025 Issues 30 to Telehealth Firms Over Misleading Marketing FDA issues 30 warning letters

These potent compounds offer a unique approach to refreshed skin and visible age management

Our team strongly advises writing the date of first use on the vial and discarding it after this 28-day period, regardless of how much is left

Overview of GLP-1 Receptor Agonists The major GLP-1 receptor agonists available on the market currently are: Dulaglutide (Trulicity) Exenatide extended release (Bydureon BCise) Exenatide (Byetta) Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) What is Dulaglutide (Trulicity) and its mechanism of action Dulaglutide, sold as Trulicity, is an injectable GLP-1 receptor agonist medication designed for the treatment of type 2 diabetes

The other surprise is the heterogeneity in therapeutic response